Table of Contents >> Show >> Hide
- What Is Alogliptin/Metformin (Kazano)?
- What Is Kazano Used For?
- How Kazano Works in Plain English
- Kazano Dosing: Strengths, How to Take It, and Missed Doses
- Pictures: What Does Kazano Look Like?
- Common Side Effects of Alogliptin/Metformin
- Serious Warnings and Red Flags
- Drug Interactions: What Should Not Be Mixed Casually?
- Kidney Function, Contrast Dye, Surgery, and Other Special Warnings
- Who Might Be a Good Candidate for Kazano?
- Brand vs. Generic: Is Kazano Still Around?
- Bottom Line
- Experience Section: What Real-World Use of Kazano Often Feels Like
- SEO Tags
If type 2 diabetes treatment plans had buddy-cop movies, alogliptin/metformin would be one of the more practical duos. One medicine helps your body squeeze more mileage out of the insulin it already makes, while the other helps your liver stop acting like it is on a sugar production bonus plan. Together, they are sold under the brand name Kazano, a prescription tablet used to improve blood sugar control in adults with type 2 diabetes.
But while Kazano can be effective, it is not a casual over-the-counter situation. It comes with important warnings, including a boxed warning for lactic acidosis, plus precautions involving the kidneys, pancreas, heart, liver, and certain drug interactions. In other words, this medication can be helpful, but it also demands respect.
This guide breaks down what Kazano is used for, how it works, common and serious side effects, interactions to watch, what the tablets look like, how dosing typically works, and what real-world use can feel like for patients and caregivers. The goal is simple: give you a clear, readable, web-ready explanation without sounding like a robot swallowed a pharmacy textbook.
What Is Alogliptin/Metformin (Kazano)?
Kazano is a combination prescription medication that contains alogliptin and metformin hydrochloride. It is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not recommended for type 1 diabetes, and it is not a treatment for diabetic ketoacidosis.
The two ingredients work differently:
- Alogliptin is a DPP-4 inhibitor. It helps increase incretin activity, which supports insulin release when blood sugar rises and reduces excess glucagon signaling after meals.
- Metformin is a biguanide. It lowers glucose production by the liver and improves the body’s response to insulin.
That complementary action is the whole point. Alogliptin is the “help your body respond better after meals” teammate, while metformin is the “let’s calm down the liver” veteran. Neither one is magic on its own, and neither replaces healthy eating, movement, or regular diabetes follow-up. But together, they can be a sensible option for adults who need both agents.
What Is Kazano Used For?
Kazano is prescribed to help lower blood sugar in adults with type 2 diabetes when treatment with both alogliptin and metformin is appropriate. In practice, that may include people who are not reaching glucose goals with diet and exercise alone, or those already using the two ingredients separately and switching to one combination tablet for convenience.
Clinical studies found that alogliptin used with metformin improved A1C and other glucose measures in adults with type 2 diabetes. That does not mean it is always the first or best option for every patient. Modern diabetes care is highly individualized. For some people, especially those with heart failure, chronic kidney disease, or a strong need for weight loss, clinicians may prioritize other medication classes first. Even so, a fixed-dose combination like Kazano can still make sense when the treatment goal is dependable glucose lowering with a simple oral regimen.
How Kazano Works in Plain English
After you eat, your body releases hormones called incretins. Alogliptin helps those hormones stick around longer, which encourages insulin release only when glucose is elevated. That is why DPP-4 inhibitors are generally considered to have a relatively low risk of hypoglycemia when used by themselves or with metformin.
Metformin, meanwhile, reduces the amount of glucose your liver releases and helps your tissues use insulin more efficiently. Think of it as turning down the faucet while also helping the sink drain better. Not glamorous, but effective.
Put those actions together, and Kazano targets blood sugar from two angles. It is not usually associated with major weight gain, and compared with some older diabetes medicines, it is less likely to trigger low blood sugar unless it is combined with insulin or an insulin secretagogue such as a sulfonylurea.
Kazano Dosing: Strengths, How to Take It, and Missed Doses
Available strengths
Kazano tablets come in two strengths:
- 12.5 mg/500 mg
- 12.5 mg/1000 mg
How it is usually taken
Kazano is typically taken by mouth twice daily with food. Taking it with meals helps reduce the stomach-related side effects commonly associated with metformin, especially early in treatment.
Maximum dose
The maximum recommended daily dose is 25 mg of alogliptin and 2000 mg of metformin.
Important dosing tips
- Take it exactly as prescribed.
- Take it with food, not on an empty stomach if you can help it.
- Do not split, cut, or break the tablets.
- If you miss a dose, take it when you remember unless it is almost time for the next dose. Do not double up.
The starting dose should be individualized based on your current regimen. That means the “right” dose is not a popularity contest between the 500 mg and 1000 mg versions. Your clinician chooses based on what you are already taking, your tolerance of metformin, kidney function, and your blood sugar goals.
Pictures: What Does Kazano Look Like?
If you are trying to identify a tablet, the pill’s imprint matters more than your cousin saying, “Yeah, that looks about right.” Kazano tablets are described as pale yellow, oblong, film-coated tablets.
- 12.5 mg/500 mg: debossed with “12.5/500” on one side and “322M” on the other
- 12.5 mg/1000 mg: debossed with “12.5/1000” on one side and “322M” on the other
If a tablet does not match the color, shape, and imprint exactly, do not assume it is Kazano. Ask a pharmacist or use a trusted pill identifier. Close enough is great for paint swatches, not prescription drugs.
Common Side Effects of Alogliptin/Metformin
Like most diabetes medications, Kazano can cause side effects. Some are common and annoying; others are uncommon but serious enough to require urgent medical attention.
Common side effects
Reported common side effects include:
- Diarrhea
- Headache
- Upper respiratory tract infection or cold-like symptoms
- Nasopharyngitis
- Back pain
- Higher blood pressure
- Urinary tract infection
- Upset stomach, gas, or indigestion
- Metallic taste or stomach discomfort in some patients taking metformin-containing therapy
Most of the milder effects show up early, especially the gastrointestinal ones. A lot of patients find that the stomach trouble fades as their body adjusts. Taking the medication with food and increasing metformin gradually can make a real difference.
When side effects deserve a same-day call
Contact a healthcare professional promptly if side effects are severe, frequent, or getting worse instead of better. A rough first week is one thing. A medication that makes you dread meals, dehydrated, dizzy, or unable to function is another.
Serious Warnings and Red Flags
Lactic acidosis
This is the big boxed warning, and it is tied to the metformin component. Lactic acidosis is rare but potentially life-threatening. Risk factors include kidney impairment, older age, heavy alcohol use, dehydration, certain interacting drugs, contrast procedures, surgery, hypoxic states, and liver problems.
Warning signs can include unusual weakness, muscle pain, trouble breathing, sleepiness, abdominal pain, nausea, vomiting, feeling cold, dizziness, or a slow or irregular heartbeat. If these symptoms appear, urgent medical evaluation is needed.
Pancreatitis
Alogliptin has been associated with acute pancreatitis. Seek help right away if you develop severe upper abdominal pain, especially if it radiates to the back or comes with vomiting.
Heart failure
Alogliptin-containing products carry a warning about heart failure risk, particularly in people who already have heart disease or kidney disease. Symptoms to watch for include shortness of breath, swelling in the legs or feet, and rapid weight gain.
Hypersensitivity reactions
Serious allergic reactions have been reported, including anaphylaxis, angioedema, and severe skin reactions such as Stevens-Johnson syndrome. Stop the medicine and get medical attention if you develop swelling of the face or throat, trouble breathing, hives, blistering, peeling, or severe rash.
Liver problems
Postmarketing reports have included hepatic failure in patients taking alogliptin. Concerning symptoms include fatigue, dark urine, loss of appetite, yellowing of the skin or eyes, or right upper abdominal pain.
Severe joint pain and bullous pemphigoid
DPP-4 inhibitors, including alogliptin, have also been linked to severe disabling joint pain and a blistering skin condition called bullous pemphigoid. These are not everyday side effects, but they are the kind you do not ignore and “see if they go away next month.”
Drug Interactions: What Should Not Be Mixed Casually?
Kazano has several meaningful interaction categories. This does not mean every combination is forbidden, but it does mean your prescriber and pharmacist should know everything you take, including supplements and as-needed medications.
Interactions that may raise lactic acidosis risk
- Carbonic anhydrase inhibitors such as topiramate, acetazolamide, zonisamide, and dichlorphenamide
- Drugs that reduce metformin clearance, including ranolazine, vandetanib, dolutegravir, and cimetidine
- Excess alcohol
Interactions that may increase low blood sugar risk
- Insulin
- Sulfonylureas and other insulin secretagogues
Kazano alone is not usually a hypoglycemia superstar, but when paired with insulin or a sulfonylurea, that risk can rise. Sometimes the other medication has to be reduced.
Drugs that may worsen blood sugar control
- Thiazide diuretics
- Corticosteroids
- Phenothiazines
- Thyroid products
- Estrogens and oral contraceptives
- Phenytoin
- Nicotinic acid
- Sympathomimetics
- Calcium channel blockers
- Isoniazid
If that list seems long, it is. That is why medication reconciliation is not just paperwork. It is one of the least glamorous but most useful parts of safe diabetes care.
Kidney Function, Contrast Dye, Surgery, and Other Special Warnings
Kazano is contraindicated if eGFR is below 30 mL/min/1.73 m² and not recommended if eGFR is 30 to 59 mL/min/1.73 m², because the fixed-dose product does not allow the lower alogliptin dosing those patients may need.
The medication may need to be temporarily stopped before or at the time of certain iodinated contrast imaging procedures, especially in patients with reduced kidney function, heart failure, alcoholism, liver disease, or those receiving intra-arterial contrast. Kidney function is then typically rechecked after 48 hours before restarting.
It may also need to be held around surgery or other procedures involving restricted food and fluids. This is not a do-it-yourself medication holiday; it should be done based on clinician instructions.
Older adults may need more frequent renal monitoring. Pediatric safety and effectiveness have not been established. In pregnancy and lactation, decisions should be individualized because available data are limited.
Who Might Be a Good Candidate for Kazano?
Kazano may be a practical fit for adults with type 2 diabetes who:
- Need both alogliptin and metformin
- Prefer an oral medication instead of adding another separate pill
- Can tolerate metformin
- Have adequate kidney function
- Are looking for glucose lowering without a high standalone risk of hypoglycemia
It may be less appealing for people with significant kidney disease, a history of pancreatitis, recurrent dehydration, major alcohol use, or those in whom other medication classes offer stronger heart, kidney, or weight benefits.
Brand vs. Generic: Is Kazano Still Around?
Kazano remains listed on Takeda’s U.S. product page, and FDA-approved generic versions of alogliptin/metformin tablets also exist. Availability at a particular pharmacy can vary, so a patient may receive the brand or a generic equivalent depending on insurance, supply, and pharmacy purchasing. That is a practical point worth knowing, especially if the pill suddenly looks different one month and your first thought is, “Well, this is unsettling.”
Bottom Line
Kazano combines alogliptin and metformin in one tablet to help adults with type 2 diabetes improve blood sugar control alongside diet and exercise. It can be convenient, effective, and relatively straightforward to take, but it is not a lightweight medication from a safety perspective. The biggest issues are kidney-related dosing limits, the boxed warning for lactic acidosis, and important warnings involving pancreatitis, heart failure, hypersensitivity reactions, and liver injury.
If the medication is prescribed thoughtfully, monitored properly, and taken with food as directed, many patients do well on it. Still, the right diabetes treatment is not the same for everyone. Kazano can be a good tool, but it is just one tool in a very crowded diabetes toolbox.
Experience Section: What Real-World Use of Kazano Often Feels Like
In real life, the experience of taking alogliptin/metformin is usually much less dramatic than the label. For many patients, the first week is mostly about logistics. They figure out which meal works best, whether breakfast and dinner are easiest, and how careful they need to be about taking it with food. A common early comment is that metformin-related stomach effects feel more noticeable than anything from the alogliptin side. People may describe loose stools, a slightly sour stomach, or that annoying metallic taste that makes coffee taste as if it lost a bet.
Another common experience is psychological rather than physical: people like the simplicity of one combination tablet. If they were already taking separate medicines, moving to a fixed-dose product can make their routine feel cleaner and easier to remember. For caregivers, that can be a genuine advantage. One bottle is easier to track than two, especially when someone is also juggling blood pressure medicine, cholesterol medication, and a suspiciously large weekly pill organizer.
Patients also often notice that Kazano is not the kind of diabetes medicine that delivers an obvious “I feel it working” sensation. Blood sugar improvement usually shows up on home readings, A1C results, or trend data rather than as a dramatic daily feeling. That can be reassuring for some people and frustrating for others. If someone is used to judging a medication by immediate symptoms, Kazano can feel quiet. Quiet is not bad. Quiet just means the numbers matter more than the drama.
Where real-world problems do show up, they often involve sick days, dehydration, or changes in kidney function. A stomach bug, poor oral intake, contrast imaging, or hospitalization can suddenly turn a routine medication into one that needs to be paused and reviewed. That is why patients who do best on Kazano are usually the ones who understand the “call your clinician if this happens” rules instead of guessing their way through them.
Pharmacists also hear a lot of questions about pill appearance. Because the brand and generic versions may differ in markings or packaging, people sometimes worry they got the wrong medicine. That concern is reasonable. The best habit is to verify the imprint and ask the pharmacy immediately if anything looks off. Medication confusion is common; silent medication confusion is the real problem.
Perhaps the most useful real-world takeaway is this: patients who succeed with Kazano usually pair it with routine, not heroics. They take it with meals, keep lab appointments, speak up about stomach issues, mention new medications, and know the emergency warning signs. It is not flashy. It is just good chronic-disease management. And in diabetes care, boring consistency is often the real overachiever.
